Neuren Pharmaceuticals | NEU - Ebit

Stock Price
12.71
Daily Change
0.47 3.84%
Monthly
-26.74%
Yearly
-2.53%
Q1 Forecast
12.80

Neuren Pharmaceuticals reported AUD171.1M in EBIT for its fiscal semester ending in December of 2024.





Ebit Change Date
Akebia Therapeutics USD 13.51M 27.82M Mar/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Avita Medical AUD -8.66M 1.61M Jun/2025
Clinuvel Pharmaceuticals AUD 32.21M 14.41M Jun/2024
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Genetic Signatures AUD -7.57M 1.09M Jun/2023
Ionis Pharmaceuticals USD -160.18M 304.96M Sep/2025
Medical Developments International AUD -12.12M 3.97M Jun/2023
Neuren Pharmaceuticals AUD 171.1M 159.25M Dec/2024
Organon & Co USD 388M 28M Sep/2025
Paradigm Biopharmaceuticals AUD -19.93M 12.02M Jun/2023
PYC Therapeutics AUD -25.84M 3M Dec/2024
Starpharma Holdings AUD -1.03M 6.36M Dec/2023
Tectonic Therapeutic USD -22.33M 4.03M Jun/2025
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025
Viatris USD 234.5M 49.1M Sep/2025
Xeris Pharmaceuticals USD 7.89M 2.46M Sep/2025